SEC Form 4 · accession 0002008790-26-000006
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dominique Christian Borie
Officer — Chief Medical Officer · Other
Period of report
Jul 13, 2026
Accepted (ET)
Jul 15, 2026 · 6:59 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001645460
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 13, 2026 | A | 31,500 | $0.00 | A | 31,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $30.92 | Jul 13, 2026 | A | 63,000 | A | — | Jul 13, 2036 | Common Stock | 63,000 | 63,000 | D |
Explanation of responses
- F1Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest in equal quarterly installments over four years from July 13, 2026, subject to the reporting person's continued service with the issuer through each vest date.
- F2The stock option becomes exercisable in equal quarterly installments over four years from July 13, 2026, subject to the reporting person's continued service with the issuer through each vest date.